[TVTX] QoQ Quarter Result on 31-Mar-2023 [#Q1]

Stock
[TVTX] Travere Therapeutics, Inc.
Announcement Date
04-May-2023
Financial Year
2023
Quarter
31-Mar-2023 [#Q1]
Profit Trend
QoQ- -31.16%
YoY- -13.64%
Quarter Report
TVTX's Result
TVTX's Financial Summary
View:
Show?
Quarter Result
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
Revenue 45,059 37,095 59,697 56,993 55,868 53,496 54,167 -11.52%
PBT -88,528 -89,229 -85,565 -86,253 -65,760 -69,511 -66,979 20.37%
Tax 68 -12 65 78 63 145 53 18.02%
NP -90,173 150,735 -85,630 -86,331 -65,823 -69,656 -67,032 21.79%
Tax Rate - - - - - - - -
Total Cost 135,232 -113,640 145,327 143,324 121,691 123,152 121,199 7.55%
Ratio Analysis
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
NP Margin -200.12 406.35 -143.44 -151.48 -117.82 -130.21 -123.75 37.65%
Per Share
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
EPS -1.18 -0.99 -1.13 -1.27 -1.03 -1.09 -1.05 8.06%
EPS Diluted -1.18 -0.99 -1.13 -1.27 -1.03 -1.09 -1.05 8.06%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.